Focus Issue: Biomarkers in Cardiovascular DiseaseClinical Research: Biomarkers in ACSProspective Evaluation of the Prognostic Implications of Improved Assay Performance With a Sensitive Assay for Cardiac Troponin I
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Scirica has received research support from Merck, Novartis, AstraZeneca, Daiichi-Sankyo, and Bristol-Myers Squibb; honoraria for educational presentations from CV Therapeutics, Novartis, Merck, Schering-Plough, Sanofi-Aventis, Lilly, and Daiichi-Sankyo; has served as a consultant for AstraZeneca, Novartis, Congentus, and Gilead; and is the recipient of an unrestricted grant from the Michael Lerner Foundation. Dr. Sabatine has received research grants from BRAHMS, diaDexus, and Ortho-Clinical Diagnostics, and is a consultant for Singulex. Dr. Jarolim has received research support from Amgen, Beckman-Coulter, Ortho Clinical Diagnostics, Roche Diagnostics, and Siemens Healthcare Diagnostics, and honoraria for educational presentations from Ortho Clinical Diagnostics. Dr. Braunwald is the chairman of the TIMI Study Group, who receives grant support from Beckman-Coulter, CV Therapeutics (now Gilead Sciences), and Roche Diagnostics. Dr. Morrow has received research/educational grant support through the TIMI Study Group from Accumetrics, AstraZeneca, Bayer Healthcare, Beckman Coulter, Bristol-Myers Squibb, CV Therapeutics, Daiichi Sankyo, Eli Lilly and Co., Genentech, Johnson & Johnson, Merck and Company, Nanosphere, Novartis Pharmaceuticals, Ortho-Clinical Diagnostics, Pfizer, Roche Diagnostics, Sanofi-Aventis, Siemens, Singulex, and Schering-Plough; has received honoraria for educational presentations from CV Therapeutics and Eli Lilly and Co.; and is a consultant/on the advisory board of AstraZeneca, Beckman-Coulter, Cardiokinetix, Gilead, Ikaria, Menarini, Molecular Insight, OrthoClinical Diagnostics, Sanofi-Aventis, Schering-Plough Research Institute, Siemens, and Roche Diagnostics.